drugset / Trial / NCT00837707

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

NCT00837707

NaSingle-groupOpen-labelTreatment

Summary

The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia

Timeline

Start
2008-06
Primary completion
2009-08
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 5 mg
Subject Aripiprazole Other / unclassified 30 mg